跳至主要内容
临床试验/DRKS00015823
DRKS00015823已完成未知

Development and piloting of a decision support tool to support decision making in the context of risk-adapted prevention for patients with pathogenic BRCA1/2 mutations - not available

niversitätsklinikum Köln0 个研究点目标入组 450 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Female

入选标准

  • 1. healthy women
  • 2. women with unilateral breast cancer (first disease without metastasis)
  • 3. sufficient decision-making ability to give informed written consent in accordance with the ICH-GCP guidelines and national/local regulations.
  • 4. sufficient language skills to complete the questionnaires

排除标准

  • 1. women with relapse or metastasis of breast cancer, ovarian cancer, or other cancer who are ill
  • 2. women unable to give informed consent
  • 3. women without sufficient knowledge of the German language

研究者

发起方
niversitätsklinikum Köln

相似试验